CellBion Co., Ltd. Sustainability Profile
CellBion Co., Ltd., headquartered in South Korea (KR), is a prominent player in the biotechnology industry, specialising in innovative cell therapy solutions. Founded in 2015, the company has rapidly established itself as a leader in regenerative medicine, focusing on the development and commercialisation of advanced cellular products. With a strong operational presence in Asia and beyond, CellBion offers unique services in cell culture and manipulation, catering to both research and clinical applications. Their flagship products, which include cutting-edge stem cell lines and customised cell solutions, are distinguished by their high purity and efficacy, setting new standards in the field. Recognised for its commitment to quality and innovation, CellBion has achieved significant milestones, positioning itself as a trusted partner in the global biotechnology landscape.
DitchCarbon Score
How does CellBion Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CellBion Co., Ltd.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CellBion Co., Ltd.'s reported carbon emissions
In 2024, CellBion Co., Ltd. reported total carbon emissions of approximately 304,343,000 kg CO2e for Scope 1 and 50,705,000 kg CO2e for Scope 2. This reflects a slight decrease from 2023, where emissions were about 313,807,000 kg CO2e for Scope 1 and 35,821,000 kg CO2e for Scope 2. The company has disclosed emissions data for both Scope 1 and Scope 2, indicating a commitment to transparency in its climate impact. Despite these figures, CellBion has not set specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The company’s emissions intensity for Scope 1 and 2 combined is reported at approximately 1,380 kg CO2e per tonne of output for 2024. As of now, there are no emissions data cascaded from a parent or related organisation, and all reported figures are directly from CellBion Co., Ltd. The absence of Scope 3 emissions data suggests a potential area for future reporting and improvement in their overall climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 313,807,000 | 000,000,000 |
| Scope 2 | 35,821,000 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is CellBion Co., Ltd.'s Industry?
How Carbon Intensive is CellBion Co., Ltd.'s Location?
CellBion Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CellBion Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
